Moirai Biodesign developes a diagnostic kit for the detection of sepsis in three hours Blog Post

Moirai Biodesign, a biotech start-up based in the Barcelona Science Park, has developed a prototype ‘kit’ based on biosensors that analyzes a blood sample and identifiesthe most important sepsis-causing pathogens and their associated antibiotic resistances, at the point of care and directly from the patient’s blood, in just three hours, a process that usually requires up to 5 days of analysis in the laboratory. The company has just received a €75,000 grant through the Startup Capital financing line from ACCIÓ to  to set about the activities derived from the execution of the initial business plan. Its objective is to market this device in hospitals, once the validation phase is completed.The kit will allow identification 

A global team involving ICUB-Tech researchers detects a type of unidentified astronomical object Blog Post

Researchers from the international collaborations LIGO and Virgo, in which the Institute of Cosmos Sciences of the UB (ICCUB) takes part under the coordination of Jordi Portell –co-director of the ICCUB Technology Unit, based in the Barcelona Science Park– have announced the discovery of an object of 2.6 solar masses, placing it firmly into so-called mass gap. That is an interval between the mass of the heaviest neutron star and the lightest blackhole, from which there were no observations yet.

 

IBEC researcher Pere Roca-Cusachs joins the European elite club in biology Blog Post

Pere Roca-Cusachs –group leader at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and associate professor at the Faculty of Medicine of the University of Barcelona (UB)– has been chosen to join the European Molecular Biology Organization (EMBO), a prestigious network that brings together some of the most brilliant researchers in the world.

 

DTI Foundation creates the IDOTCOVID international open access database Blog Post

Thanks to its global network of collaborators, the DTI Foundation –based in the Barcelona Science Park– has created the International Database on Organ Donation and Transplantation COVID-19 (IDOTCOVID) with the collaboration of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) –Hospital Clínic de Barcelona and with the endorsement of the IRODaT registry and the LIDOBS observatory. The objective of this initiative is to provide clinical evidence in the scientific community towards the establishment of treatment and management protocols for patients infected with SARS-CoV2.

 

Chemotargets opens an investment round to enter a new phase of growth Blog Post

Chemotargets, a global leader in predictive analytics solutions for the pharma and biotech sector, begins a phase of transformation to expand its activity in the drug discovery sector as a biotechnology company. The company, based in the Barcelona Science Park, is opening an investment round to undertake the transformation of its business model, with tadvice and support of GENESIS Biomed, also located in the Park, and CREA Inversión. 

 

Meteosim and Olfasense join forces against environmental pollution due to odours Blog Post

The Catalan company Meteosim, based at the Barcelona Science Park, has signed an alliance with the German multinationa Olfasense to provide a comprehensive solution in the smart management of bad odours and resulting conflicts. Through this alliance, the two companies integrate their leading technology in the Ortelium platform, which enables the analysis of the environmental impact of past, current and future episodes, and includes advanced complaint management tools, facilitating smart decision-making in real time.

 

Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019” Blog Post

Salvador Aznar Benitah, ICREA at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, as received the “Premio Carmen y Severo Ochoa de Investigación en Biología Molecular” in acknowledgement of his work on adult stem cells and the relation of these with circadian rhythms and metastasis, and also in recognition of his recent entrepreneurial activity as co-founder of Ona Therapeutics.

 

CataloniaBioHT participates in the Annual Advisory Committee of the Catalonia’s Cluster Programme Blog Post

Last Thursday, the president of CataloniaBio & HealthTech (CataloniaBioHT), Jaume Amat, participated in the Annual Advisory Committee of the Catalonia’s Cluster Programme, promoted by ACCIÓ, alongside the other presidents of the 30 accredited clusters. The association, founded in 2017 as a result of the merger of CataloniaBio and HeathTech Cluster and headquartered in the Barcelona Science Park, has over 160 companies and agents in the field of biomedicine and health.